Micro Cap Growth Fund
Daily price w/o sales charge as of 11/29/2024
$18.52
$0.06
YTD Returns w/o sales charge as of 11/29/2024
33.53%
Overall Morningstar RatingsSmall Growth
as of 10/31/2024
Morningstar rated the Lord Abbett Micro Cap Growth Fund class A share 2, 4 and 4 stars among 542, 521 and 399 Small Growth Funds for the overall rating and the 3, 5 and 10 year periods ended 10/31/2024, respectively.
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 10/31/2024
- Total Net Assets
- $194.84 M
- Inception Date
- 05/01/2000
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 1.37%
- Fund Net Expense Ratio
- 1.37%
- Number of Holdings
- 64
- Minimum Initial Investment
- $1,500+
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 19.03% | 49.41% | -5.17% | 13.66% | 12.71% | 10.06% |
| Lipper Category Avg. Small-Cap Growth Funds | 11.71% | 34.18% | -3.50% | 8.99% | 9.12% | - |
| Russell Microcap® Growth Index | 13.24% | 43.01% | -7.53% | 7.11% | 5.21% | - |
| w/ sales charge | 12.16% | 40.87% | -7.02% | 12.33% | 12.05% | 9.79% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 15.14% | 28.07% | -4.23% | 13.67% | 13.16% | 9.94% |
| Lipper Category Avg. Small-Cap Growth Funds | 13.34% | 26.11% | -1.27% | 9.68% | 9.84% | - |
| Russell Microcap® Growth Index | 9.29% | 26.38% | -8.31% | 6.86% | 5.42% | - |
| w/ sales charge | 8.49% | 20.71% | -6.10% | 12.33% | 12.49% | 9.68% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 10/31/2024View Portfolio
| Holding | Assets |
|---|---|
| Tarsus Pharmaceuticals Inc | 3.2% |
| VSE Corp | 2.7% |
| Zeta Global Holdings Corp | 2.6% |
| Alkami Technology Inc | 2.6% |
| PROCEPT BioRobotics Corp | 2.5% |
| Vital Farms Inc | 2.3% |
| Sweetgreen Inc | 2.3% |
| Arcellx Inc | 2.2% |
| Willdan Group Inc | 2.2% |
| GeneDx Holdings Corp | 2.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 10/31/2024View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 19.03% | 49.41% | -5.17% | 13.66% | 12.71% | 10.06% |
| Lipper Category Avg. Small-Cap Growth Funds | 11.71% | 34.18% | -3.50% | 8.99% | 9.12% | - |
| Russell Microcap® Growth Index | 13.24% | 43.01% | -7.53% | 7.11% | 5.21% | - |
| w/ sales charge | 12.16% | 40.87% | -7.02% | 12.33% | 12.05% | 9.79% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 15.14% | 28.07% | -4.23% | 13.67% | 13.16% | 9.94% |
| Lipper Category Avg. Small-Cap Growth Funds | 13.34% | 26.11% | -1.27% | 9.68% | 9.84% | - |
| Russell Microcap® Growth Index | 9.29% | 26.38% | -8.31% | 6.86% | 5.42% | - |
| w/ sales charge | 8.49% | 20.71% | -6.10% | 12.33% | 12.49% | 9.68% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
| Year | Fund Returns | Russell Microcap® Growth Index |
|---|
| 2023 | 5.88% | 9.11% |
| 2022 | -29.27% | -29.76% |
| 2021 | 3.46% | 0.88% |
| 2020 | 79.42% | 40.13% |
| 2019 | 34.57% | 23.33% |
| 2018 | 2.74% | -14.18% |
| 2017 | 38.43% | 16.65% |
| 2016 | 2.07% | 6.86% |
| 2015 | -6.38% | -3.85% |
| 2014 | 10.83% | 4.30% |
| 2013 | 78.53% | - |
| 2012 | 2.35% | - |
| 2011 | -5.87% | - |
| 2010 | 33.77% | - |
| 2009 | 52.61% | - |
| 2008 | -46.45% | - |
| 2007 | 22.76% | - |
| 2006 | 25.37% | - |
| 2005 | 2.55% | - |
| 2004 | 25.89% | - |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|
| 2024 | 7.64% | 0.07% | 6.89% | - |
| 2023 | 5.50% | 4.20% | -13.40% | 11.23% |
| 2022 | -17.22% | -22.57% | 8.17% | 2.02% |
| 2021 | 12.29% | -0.15% | -9.42% | 1.87% |
| 2020 | -24.28% | 47.61% | 17.48% | 36.65% |
| 2019 | 22.67% | 7.47% | -13.91% | 18.57% |
| 2018 | 5.24% | 15.77% | 10.08% | -23.39% |
| 2017 | 9.00% | 8.12% | 13.61% | 3.39% |
| 2016 | -13.70% | 6.01% | 14.49% | -2.55% |
| 2015 | 7.33% | 4.15% | -16.30% | 0.06% |
| 2014 | 7.92% | -6.53% | -6.55% | 17.58% |
| 2013 | 21.83% | 15.00% | 17.29% | 8.65% |
| 2012 | 17.67% | -9.76% | 1.32% | -4.87% |
| 2011 | 4.82% | 0.11% | -21.90% | 14.86% |
| 2010 | 6.60% | -8.74% | 15.08% | 19.49% |
| 2009 | -0.95% | 31.46% | 13.47% | 3.29% |
| 2008 | -23.22% | 4.46% | -5.93% | -29.02% |
| 2007 | 5.64% | 9.81% | 4.01% | 1.76% |
| 2006 | 17.15% | -9.83% | 1.22% | 17.25% |
| 2005 | -9.50% | 5.88% | 6.91% | 0.10% |
| 2004 | 12.33% | 1.65% | -11.11% | 24.03% |
| 2003 | -3.55% | 27.29% | 11.68% | 8.93% |
| 2002 | -0.18% | -12.74% | -21.79% | 1.33% |
| 2001 | 2.34% | 12.03% | -21.11% | 29.32% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 10/31/2024
The chart begins on the Fund's inception date of 05/01/2000.
Based on a hypothetical Class A share investment of $10,000 on 05/01/2000 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Tarsus Pharmaceuticals Inc | Health Care | 3.2% |
| VSE Corp | Industrials | 2.7% |
| Zeta Global Holdings Corp | Information Technology | 2.6% |
| Alkami Technology Inc | Information Technology | 2.6% |
| PROCEPT BioRobotics Corp | Health Care | 2.5% |
| Vital Farms Inc | Consumer Staples | 2.3% |
| Sweetgreen Inc | Consumer Discretionary | 2.3% |
| Arcellx Inc | Health Care | 2.2% |
| Willdan Group Inc | Industrials | 2.2% |
| GeneDx Holdings Corp | Health Care | 2.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Zeta Global Holdings Corp | Information Technology | 2.9% |
| Green Brick Partners Inc | Consumer Discretionary | 2.6% |
| Longboard Pharmaceuticals Inc | Health Care | 2.5% |
| Tarsus Pharmaceuticals Inc | Health Care | 2.4% |
| Vital Farms Inc | Consumer Staples | 2.4% |
| Sweetgreen Inc | Consumer Discretionary | 2.3% |
| Vera Therapeutics Inc | Health Care | 2.3% |
| Alkami Technology Inc | Information Technology | 2.3% |
| Arcellx Inc | Health Care | 2.3% |
| VSE Corp | Industrials | 2.3% |
| PROCEPT BioRobotics Corp | Health Care | 2.2% |
| Agilysys Inc | Information Technology | 2.2% |
| OSI Systems Inc | Information Technology | 2.1% |
| Chefs' Warehouse Inc/The | Consumer Staples | 2.0% |
| Evolus Inc | Health Care | 2.0% |
| Willdan Group Inc | Industrials | 2.0% |
| Stride Inc | Consumer Discretionary | 2.0% |
| Kratos Defense & Security Solutions Inc | Industrials | 2.0% |
| Primoris Services Corp | Industrials | 1.9% |
| Blue Bird Corp | Industrials | 1.9% |
| UFP Technologies Inc | Health Care | 1.8% |
| Cellebrite DI Ltd | Information Technology | 1.8% |
| CRA International Inc | Industrials | 1.7% |
| Natural Grocers by Vitamin Cottage Inc | Consumer Staples | 1.7% |
| Vita Coco Co Inc/The | Consumer Staples | 1.6% |
| RxSight Inc | Health Care | 1.6% |
| Impinj Inc | Information Technology | 1.5% |
| Arlo Technologies Inc | Information Technology | 1.5% |
| OneSpaWorld Holdings Ltd | Consumer Discretionary | 1.5% |
| Mirum Pharmaceuticals Inc | Health Care | 1.5% |
| Criteo SA | Communication Services | 1.5% |
| Paymentus Holdings Inc | Financials | 1.4% |
| Weave Communications Inc | Information Technology | 1.4% |
| Piper Sandler Cos | Financials | 1.4% |
| CareDx Inc | Health Care | 1.4% |
| Aspen Aerogels Inc | Materials | 1.3% |
| Universal Technical Institute Inc | Consumer Discretionary | 1.3% |
| Sapiens International Corp NV | Information Technology | 1.3% |
| Janux Therapeutics Inc | Health Care | 1.3% |
| Credo Technology Group Holding Ltd | Information Technology | 1.2% |
| Sterling Infrastructure Inc | Industrials | 1.2% |
| Veracyte Inc | Health Care | 1.2% |
| Crinetics Pharmaceuticals Inc | Health Care | 1.2% |
| ICF International Inc | Industrials | 1.1% |
| Viridian Therapeutics Inc | Health Care | 1.1% |
| Xenon Pharmaceuticals Inc | Health Care | 1.1% |
| Grid Dynamics Holdings Inc | Information Technology | 1.1% |
| Avadel Pharmaceuticals PLC | Health Care | 1.0% |
| Enliven Therapeutics Inc | Health Care | 1.0% |
| Life360 Inc | Information Technology | 1.0% |
| Nurix Therapeutics Inc | Health Care | 1.0% |
| Grindr Inc | Communication Services | 1.0% |
| IMAX Corp | Communication Services | 0.9% |
| Proficient Auto Logistics Inc | Industrials | 0.9% |
| Argan Inc | Industrials | 0.8% |
| Avid Bioservices Inc | Health Care | 0.8% |
| Immunome Inc | Health Care | 0.8% |
| TransMedics Group Inc | Health Care | 0.8% |
| Payoneer Global Inc | Financials | 0.8% |
| Bancorp Inc/The | Financials | 0.7% |
| Artivion Inc | Health Care | 0.7% |
| Aris Water Solutions Inc | Industrials | 0.7% |
| TaskUS Inc | Industrials | 0.7% |
| Rhythm Pharmaceuticals Inc | Health Care | 0.7% |
| TWFG Inc | Financials | 0.6% |
| Twist Bioscience Corp | Health Care | 0.6% |
| Centessa Pharmaceuticals PLC | Health Care | 0.5% |
| Ambarella Inc | Information Technology | 0.5% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 10/31/2024
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services | 0.0% | |
| Real Estate | 0.0% | |
| Utilities | 0.0% | |
| Consumer Discretionary |
 0.1%
|
|
| Consumer Staples |
0.4%
|
|
| Energy | 0.0% | |
| Financials |
1.4%
|
|
| Health Care |
2.2%
|
|
| Industrials |
2.0%
|
|
| Information Technology |
0.7%
|
|
| Materials |
1.3%
|
Portfolio Details as of 10/31/2024
- Total Net Assets
- $194.84 M
- Number of Holdings
- 64
- Weighted Average Market Cap.
- 2.6 B
- P/B Ratio
- 5.8x
- P/E Ratio
- 27.1x
To view definitions for the above Portfolio Details, Click here.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 11/29/2024
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 11/20/2001 | 11/21/2001 | 11/21/2001 | $0.00740 | $10.09 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/23/2020 | 11/24/2020 | $2.8043 | $2.2741 | $5.0784 | $15.43 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 11/29/2024
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $19.65 |
| $50,000 to $99,999 | 4.75% | 4.00% | $19.44 |
| $100,000 to $249,999 | 3.95% | 3.25% | $19.28 |
| $250,000 to $499,999 | 2.75% | 2.25% | $19.04 |
| $500,000 to $999,999 | 1.95% | 1.75% | $18.89 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $18.52 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 10/31/2024
| Fund Gross Expense Ratio | 1.37% |
| Fund Net Expense Ratio | 1.37% |
| Adjusted Expense Ratio | - |
Fund Documents
Fund Documents
|
0Documents selected
|
||||
|---|---|---|---|---|
|
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
|
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
||||
|
Statutory Prospectus
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
||||
|
Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
Semi-Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
Fact Sheet
Publish Date:11/03/2015
|